News Story #19393
New Products and Aggressive Initiatives Help Reference and Specialty Labs Boost Revenues
Read MorePosted by Clinical Lab Products | Apr 1, 2004 | Cancer, Miscellaneous |
New Products and Aggressive Initiatives Help Reference and Specialty Labs Boost Revenues
Read MorePosted by Clinical Lab Products | Mar 10, 2004 | Miscellaneous |
Dade Behring Signs Manufacturing Licensing Agreement for FSAP Dade Behring and Aventis Behring LLC have signed a license agreement that provides Dade Behring with worldwide in vitro diagnostic rights to any Aventis Behring inventions that relate t
Read MorePosted by Clinical Lab Products | Mar 6, 2004 | Miscellaneous |
Health care is on everyones mind lately, and those who work in the health care industry could find themselves overwhelmed by the myriad issues. What will be done about the rising costs of health care and prescription drugs, and how will it a
Read MorePosted by Clinical Lab Products | Mar 2, 2004 | Miscellaneous |
For urgent care, point-of-care, and physician office laboratories
Read MorePosted by Clinical Lab Products | Mar 1, 2004 | Miscellaneous |
By Marleen and Gary Wolfe The basic theory underlying the physicians office laboratory (POL) is deceptively simple: If physicians can run certain critical assays on patients while they are in the office, the patients can be diagnosed and tr
Read More